Lead Researcher: Professor Finlay Macrae
Institution: Melbourne Health
Funding: $290,340.50
Funding Duration: 2016 – 2018
The Research
A trial to establish whether lower doses of aspirin are equally effective for cancer prevention making public health messages uniform across cardiovascular disease and cancer.
share
.svg)
